Investing Ideas
/
Polish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Polish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Genomed Spólka Akcyjna

Market Cap: zł31.7m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł24.00

-16.7%

-8.4%